EBITDA Summary of Xiamen Kingdomway Group Company

Xiamen Kingdomway Group Company's latest annual EBITDA in 2023 was 588.78 Million CNY , down -60.2% from previous year.
Xiamen Kingdomway Group Company's latest quarterly EBITDA in 2024 Q1 was 102.71 Million CNY , up 35.94% from previous quarter.
Xiamen Kingdomway Group Company reported an annual EBITDA of 554.83 Million CNY in 2022, down -39.37% from previous year.
Xiamen Kingdomway Group Company reported an annual EBITDA of 1.14 Billion CNY in 2021, down -6.9% from previous year.
Xiamen Kingdomway Group Company reported a quarterly EBITDA of 102.71 Million CNY for 2024 Q1, up 35.94% from previous quarter.
Xiamen Kingdomway Group Company reported a quarterly EBITDA of 95.3 Million CNY for 2024 Q2, down -18.35% from previous quarter.

Annual EBITDA Chart of Xiamen Kingdomway Group Company (2023 - 2008)

Historical Annual EBITDA of Xiamen Kingdomway Group Company (2023 - 2008)

Year	EBITDA	EBITDA Growth
2023	588.78 Million CNY	-60.2%
2022	554.83 Million CNY	-39.37%
2021	1.14 Billion CNY	-6.9%
2020	1.29 Billion CNY	22.63%
2019	807.64 Million CNY	-4.39%
2018	959.89 Million CNY	64.72%
2017	663.54 Million CNY	46.83%
2016	471.09 Million CNY	113.14%
2015	210.55 Million CNY	-14.82%
2014	255.43 Million CNY	64.03%
2013	156.88 Million CNY	-3.86%
2012	156.3 Million CNY	-13.5%
2011	190.97 Million CNY	-5.72%
2010	197.25 Million CNY	95.46%
2009	94.88 Million CNY	38.13%
2008	73.96 Million CNY	0.0%

Year	EBITDA	EBITDA Growth
2024 Q3	123 Million CNY	13.47%
2024 Q1	102.71 Million CNY	35.94%
2024 Q2	95.3 Million CNY	-18.35%
2023 Q2	123.11 Million CNY	0.02%
2023 Q1	123.08 Million CNY	26.33%
2023 FY	- CNY	-60.2%
2023 Q3	93.72 Million CNY	-23.87%
2023 Q4	47.38 Million CNY	-49.44%
2022 Q2	183.4 Million CNY	16.06%
2022 Q4	97.43 Million CNY	-12.57%
2022 Q3	111.43 Million CNY	-39.24%
2022 FY	- CNY	-39.37%
2022 Q1	158.03 Million CNY	-31.26%
2021 Q4	229.9 Million CNY	8.38%
2021 Q1	349.67 Million CNY	45.13%
2021 Q2	278.41 Million CNY	-20.38%
2021 Q3	212.13 Million CNY	-23.81%
2021 FY	- CNY	-6.9%
2020 FY	- CNY	22.63%
2020 Q2	333.68 Million CNY	21.55%
2020 Q4	240.94 Million CNY	-40.07%
2020 Q3	402.05 Million CNY	20.49%
2020 Q1	274.51 Million CNY	-4.34%
2019 Q1	171.51 Million CNY	-25.12%
2019 Q3	205.37 Million CNY	-33.8%
2019 Q4	286.97 Million CNY	39.73%
2019 FY	- CNY	-4.39%
2019 Q2	310.2 Million CNY	80.87%
2018 Q2	183.63 Million CNY	-55.75%
2018 Q4	229.03 Million CNY	4.04%
2018 FY	- CNY	64.72%
2018 Q1	414.98 Million CNY	36.44%
2018 Q3	220.15 Million CNY	19.89%
2017 Q2	117.72 Million CNY	46.53%
2017 FY	- CNY	46.83%
2017 Q4	304.15 Million CNY	169.64%
2017 Q3	112.8 Million CNY	-4.19%
2017 Q1	80.34 Million CNY	-39.34%
2016 FY	- CNY	113.14%
2016 Q1	64.74 Million CNY	1198.6%
2016 Q2	111.92 Million CNY	72.89%
2016 Q3	89.45 Million CNY	-20.08%
2016 Q4	132.44 Million CNY	48.06%
2015 Q2	64.11 Million CNY	30.87%
2015 Q3	47.39 Million CNY	-26.08%
2015 Q4	-5.89 Million CNY	-112.43%
2015 FY	- CNY	-14.82%
2015 Q1	48.98 Million CNY	-12.06%
2014 FY	- CNY	64.03%
2014 Q1	47.65 Million CNY	-2.31%
2014 Q4	55.71 Million CNY	18.37%
2014 Q3	47.06 Million CNY	-31.77%
2014 Q2	68.98 Million CNY	44.75%
2013 Q1	18.87 Million CNY	-56.81%
2013 Q4	48.78 Million CNY	72.18%
2013 Q3	28.33 Million CNY	8.06%
2013 FY	- CNY	-3.86%
2013 Q2	26.21 Million CNY	38.95%
2012 Q3	20.37 Million CNY	-15.05%
2012 Q2	23.98 Million CNY	-44.04%
2012 FY	- CNY	-13.5%
2012 Q1	42.85 Million CNY	165.66%
2012 Q4	43.68 Million CNY	114.44%
2011 Q4	16.13 Million CNY	-73.74%
2011 Q2	48.35 Million CNY	-0.3%
2011 Q1	48.5 Million CNY	56.3%
2011 FY	- CNY	-5.72%
2011 Q3	61.41 Million CNY	27.01%
2010 Q4	31.03 Million CNY	-9.32%
2010 Q3	34.22 Million CNY	0.0%
2010 FY	- CNY	95.46%
2009 FY	- CNY	38.13%
2008 FY	- CNY	0.0%

Peer EBITDA Comparison of Xiamen Kingdomway Group Company

Name	EBITDA	EBITDA Difference
Shenzhen Neptunus Bioengineering Co., Ltd.	-141.51 Million CNY	516.067%
Anhui Fengyuan Pharmaceutical Co., Ltd.	388.66 Million CNY	-51.488%
Dong-E-E-Jiao Co.,Ltd.	1.53 Billion CNY	61.755%
Livzon Pharmaceutical Group Inc.	3.29 Billion CNY	82.144%
Hainan Haiyao Co., Ltd.	152.19 Million CNY	-286.857%
Tus-Pharmaceutical Group Co., Ltd.	62.18 Million CNY	-846.857%
Jilin Aodong Pharmaceutical Group Co., Ltd.	1.87 Billion CNY	68.655%
Changchun High-Tech Industries (Group) Inc.	6.09 Billion CNY	90.341%
Apeloa Pharmaceutical Co.,Ltd	1.79 Billion CNY	67.142%
PKU HealthCare Corp.,Ltd.	132.39 Million CNY	-344.728%
Chengdu Huasun Technology Group Inc., Ltd.	74.04 Million CNY	-695.172%
Dezhan Healthcare Company Limited	219.36 Million CNY	-168.409%
Jinling Pharmaceutical Company Limited	249.63 Million CNY	-135.862%
Jiuzhitang Co., Ltd.	460.28 Million CNY	-27.918%
Huapont Life Sciences Co., Ltd.	2.12 Billion CNY	72.323%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	945.42 Million CNY	37.723%
Shandong Wohua Pharmaceutical Co., Ltd.	87.98 Million CNY	-569.15%
Hengkang Medical Group Co., Ltd.	348.09 Million CNY	-69.144%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	453.78 Million CNY	-29.75%
Qianjiang Yongan Pharmaceutical Co., Ltd.	141.6 Million CNY	-315.783%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	124.71 Million CNY	-372.085%
Jinhe Biotechnology CO., LTD.	345.42 Million CNY	-70.453%
Teyi Pharmaceutical Group Co.,Ltd	369.46 Million CNY	-59.362%
Kunming Longjin Pharmaceutical Co., Ltd.	-31.19 Million CNY	1987.264%
Beijing Aosaikang Pharmaceutical Co., Ltd.	-112.74 Million CNY	622.221%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	1.38 Billion CNY	57.601%
Anhui Huangshan Capsule Co., Ltd.	118.18 Million CNY	-398.177%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	166.4 Million CNY	-253.819%
Zhuhai Rundu Pharmaceutical Co., Ltd.	215.02 Million CNY	-173.823%
Huaren Pharmaceutical Co., Ltd.	431.65 Million CNY	-36.403%
Tianjin Ringpu Bio-Technology Co.,Ltd.	711.43 Million CNY	17.239%
Shanxi Zhendong Pharmaceutical Co.,Ltd	94.75 Million CNY	-521.384%
Fuan Pharmaceutical (Group) Co., Ltd.	528.99 Million CNY	-11.303%
Hybio Pharmaceutical Co., Ltd.	-233.61 Million CNY	352.031%
Baotou Dongbao Bio-Tech Co.,Ltd	236.24 Million CNY	-149.226%
Hunan Er-Kang Pharmaceutical Co., Ltd	12.02 Million CNY	-4797.37%
Changjiang Pharmaceutical Group Co., Ltd.	-572.69 Million CNY	202.809%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	383.11 Million CNY	-53.683%
Fujian Cosunter Pharmaceutical Co., Ltd.	-190.85 Million CNY	408.492%
Beijing Science Sun Pharmaceutical Co., Ltd.	7.7 Million CNY	-7543.533%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	87.94 Million CNY	-569.454%
Hainan Poly Pharm. Co., Ltd	309.33 Million CNY	-90.337%
Jiangxi Synergy Pharmaceutical Co., Ltd.	192.54 Million CNY	-205.796%
Wuhan Hiteck Biological Pharma Co.,Ltd	-73.65 Million CNY	899.356%
Shandong Xinhua Pharmaceutical Company Limited	1.09 Billion CNY	46.259%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	435.22 Million CNY	-35.282%
PharmaBlock Sciences (Nanjing), Inc.	380.8 Million CNY	-54.616%
Jinghua Pharmaceutical Group Co., Ltd.	417.61 Million CNY	-40.989%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	-43.99 Million CNY	1438.329%
Betta Pharmaceuticals Co., Ltd.	696.09 Million CNY	15.416%
Tibet AIM Pharm. Inc.	50.76 Million CNY	-1059.892%
Shenzhen Kangtai Biological Products Co., Ltd.	1.29 Billion CNY	54.537%
Shandong Shanda Wit Science and Technology Co., Ltd.	1.39 Billion CNY	57.912%
Pacific Shuanglin Bio-pharmacy Co., LTD	841.98 Million CNY	30.072%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	300.14 Million CNY	-96.168%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	127.06 Million CNY	-363.373%
Walvax Biotechnology Co., Ltd.	938.22 Million CNY	37.245%
Sunflower Pharmaceutical Group Co.,Ltd	1.54 Billion CNY	61.937%
Harbin Gloria Pharmaceuticals Co., Ltd	275.28 Million CNY	-113.882%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	4.68 Billion CNY	87.441%
Hunan Hansen Pharmaceutical Co., Ltd.	280.66 Million CNY	-109.783%
Changzhou Qianhong Biopharma CO.,LTD	278.66 Million CNY	-111.285%
Shenzhen Weiguang Biological Products Co., Ltd.	350.21 Million CNY	-68.122%
Honz Pharmaceutical Co., Ltd.	133.53 Million CNY	-340.928%
Northeast Pharmaceutical Group Co., Ltd.	1.19 Billion CNY	50.79%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	217.47 Million CNY	-170.737%
Guizhou Xinbang Pharmaceutical Co., Ltd.	654.01 Million CNY	9.974%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	477.37 Million CNY	-23.338%
Zhejiang Yatai Pharmaceutical Co., Ltd.	76.31 Million CNY	-671.534%
Zhejiang NHU Company Ltd.	5.24 Billion CNY	88.781%
ApicHope Pharmaceutical Co., Ltd	464.04 Million CNY	-26.882%
Shanghai Kaibao Pharmaceutical CO.,Ltd	375.33 Million CNY	-56.869%
Beijing SL Pharmaceutical Co., Ltd.	610.29 Million CNY	3.524%
Yunnan Baiyao Group Co.,Ltd	5.2 Billion CNY	88.693%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	127.72 Million CNY	-360.995%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	228.9 Million CNY	-157.222%
Guangdong Lifestrong Pharmacy Co., Ltd.	50.95 Million CNY	-1055.387%
Huadong Medicine Co., Ltd	4.61 Billion CNY	87.247%
Jiangsu Nhwa Pharmaceutical Co., LTD	1.33 Billion CNY	56.03%
Harbin Medisan Pharmaceutical Co., Ltd.	183.66 Million CNY	-220.577%
LanZhou Foci Pharmaceutical Co.,Ltd.	135.36 Million CNY	-334.948%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	1.04 Billion CNY	43.764%
Beijing Beilu Pharmaceutical Co., Ltd	36.44 Million CNY	-1515.516%
Nanjing Hicin Pharmaceutical Co., Ltd.	97 Million CNY	-506.986%
Renhe Pharmacy Co., Ltd.	1.05 Billion CNY	43.96%
Chongqing Pharscin Pharmaceutical Co., Ltd.	125.84 Million CNY	-367.853%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	863.95 Million CNY	31.851%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	-320.08 Million CNY	283.944%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	-298.6 Million CNY	297.176%

Global Stocks Search

Xiamen Kingdomway Group Company (002626.SZ)

EBITDA Summary of Xiamen Kingdomway Group Company

Annual EBITDA Chart of Xiamen Kingdomway Group Company (2023 - 2008)

Historical Annual EBITDA of Xiamen Kingdomway Group Company (2023 - 2008)

Peer EBITDA Comparison of Xiamen Kingdomway Group Company